DermaRite Industries LLC, a New Jersey-based healthcare manufacturer, has voluntarily recalled several products, including hand soap, cleanser, and analgesic, due to microbial contamination. The Food and Drug Administration (FDA) shared the recall notice, warning that the contaminated items could cause life-threatening health problems.
The FDA posted DermaRite’s recall announcement dated August 8, 2025, urging distributors and customers to “immediately examine available inventory and destroy all affected products.”
Contamination Linked to Dangerous Bacteria
The recalled products contain Burkholderia cepacia, a bacteria known to cause “serious and life-threatening infections,” according to DermaRite. The infection can spread into the bloodstream of immunocompromised individuals, potentially causing life-threatening sepsis.
“To date, DermaRite has not received any reports of adverse events related to this recall,” the company stated.
What Is Burkholderia cepacia?
Burkholderia cepacia is a group of bacteria that primarily affects people with weakened immune systems or chronic lung diseases such as cystic fibrosis, says the Centers for Disease Control (CDC).
These bacteria live in water and soil and can spread from person to person. Because of their resistance to antibiotics, infections caused by Burkholderia cepacia can be hard to treat. Early symptoms include fever and fatigue.
Products Included in the Recall
- DermaKleen — Antiseptic lotion soap
- DermaSarra — Analgesic
- KleenFoam — Antimicrobial foam soap
- PeriGiene — Antiseptic cleanser
Why Were These Products Recalled?
DermaRite recalled these products because contamination with Burkholderia cepacia could lead to “life-threatening” health complications.
Does the FDA Endorse DermaRite?
No. The FDA does not endorse DermaRite Industries LLC. The company voluntarily issued this recall and shared the information publicly for consumer safety.
